Ongeno is a medical technology developer that specializes in the development of treatments for a variety of autoimmune diseases.
Ongeno has raised $3.6M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2025.
Ongeno is headquartered in Kraków, Poland.
Ongeno is a medical technology developer that specializes in the development of treatments for a variety of autoimmune diseases.
Ongeno is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ongeno — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/ongeno. Accessed August 18, 2026.
VCBacked. (2025). Ongeno — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/ongeno
{{cite web |title=Ongeno — Funding & Investors |url=https://www.vcbacked.co/company/ongeno |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated